Baykal, N. D. Et Al. 2024. Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), hypoxia-induced factor-1 alpha (HIF-1α) and apelin 13 levels as new potential biomarkers for pulmonary thromboembolism: A prospective clinical study. Respiratory Medicine , vol.233 .

Baykal, N. D., Mermit , B., Alp, H. H., & Yıldız, H., (2024). Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), hypoxia-induced factor-1 alpha (HIF-1α) and apelin 13 levels as new potential biomarkers for pulmonary thromboembolism: A prospective clinical study. Respiratory Medicine , vol.233.

Baykal, Nuruban Et Al. "Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), hypoxia-induced factor-1 alpha (HIF-1α) and apelin 13 levels as new potential biomarkers for pulmonary thromboembolism: A prospective clinical study," Respiratory Medicine , vol.233, 2024

Baykal, Nuruban D. Et Al. "Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), hypoxia-induced factor-1 alpha (HIF-1α) and apelin 13 levels as new potential biomarkers for pulmonary thromboembolism: A prospective clinical study." Respiratory Medicine , vol.233, 2024

Baykal, N. D. Et Al. (2024) . "Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), hypoxia-induced factor-1 alpha (HIF-1α) and apelin 13 levels as new potential biomarkers for pulmonary thromboembolism: A prospective clinical study." Respiratory Medicine , vol.233.

@article{article, author={Nuruban Delal Baykal Et Al. }, title={Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), hypoxia-induced factor-1 alpha (HIF-1α) and apelin 13 levels as new potential biomarkers for pulmonary thromboembolism: A prospective clinical study}, journal={Respiratory Medicine}, year=2024}